✨ Free AI Report
IMAC Holdings, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview IMAC Holdings, Inc.
Research Preview

IMAC Holdings, Inc.: Business Overview, Financials & Competitive Analysis

IMAC Holdings operates through its subsidiary Ignite Proteomics, providing proteomic product and precision medicine services based on activated protein analysis for cancer treatment in the United States. The company o...

Analyst-debate audio for IMAC Holdings, Inc.

AskCyborg analysts argue the bull and bear cases for IMAC Holdings, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
IMAC Holdings, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
3/ 10Challenged

Cyborg Score thesis

Early-stage biotech platform with niche precision oncology focus, but severely capital-constrained and illiquid execution...

Read the full analyst-debate transcript →
Industry Oncology diagnostics and precision medicine
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest IMAC Holdings, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

IMAC Holdings, Inc. Overview

Pro stress-test →

IMAC Holdings operates through its subsidiary Ignite Proteomics, providing proteomic product and precision medicine services based on activated protein analysis for cancer treatment in the United States. The company offers a reverse phase protein array (RPPA) platform that quantifies protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development.

Strategic Profile

Pro stress-test →

The company has announced research collaborations with academic institutions including Vanderbilt University Medical Center to advance immuno-oncology biomarker discovery. As a micro-cap OTC-traded biotech firm focused on protein analysis and cancer diagnostics, IMAC is positioned at the intersection of precision oncology and biomarker-driven treatment development.

Competitive Landscape

Pro stress-test →

IMAC competes in the oncology diagnostics and biomarker discovery space against established players including Tempus AI, Foundation Medicine, and academic medical centers conducting similar proteomics research. However, the company lacks the scale, funding, and commercial infrastructure of these competitors.

Industry Context

IMAC Holdings, Inc. operates in Oncology diagnostics and precision medicine.

Key facts

Founded: 2000 · Headquarters: Brentwood, US · Employees: 15 · Revenue: N/A · Market cap: $217K

What the analysts stress-tested

The top findings that survived the multi-agent debate for IMAC Holdings, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when IMAC Holdings, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

TempusAI-powered oncology diagnostics and precision medicineFoundation MedicineComprehensive genomic profiling for cancer treatmentGuardant HealthLiquid biopsy and precision oncology diagnostics

Compare IMAC Holdings, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

IMAC Holdings, Inc. operates in Oncology diagnostics and precision medicine. See how the rest of the sector scores on the Cyborg framework.

Browse Oncology diagnostics and precision medicine research →
NEW · MCP server

Ask your AI assistant about IMAC Holdings, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare IMAC Holdings, Inc. and its top competitor on Cyborg Score”
“What did IMAC Holdings, Inc. do this quarter?”
“Is IMAC Holdings, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does IMAC Holdings, Inc. do?+
IMAC Holdings operates through its subsidiary Ignite Proteomics, providing proteomic product and precision medicine services based on activated protein analysis for cancer treatment in the United States. The company o...
What is IMAC Holdings, Inc.'s Cyborg Score?+
IMAC Holdings, Inc. has a Cyborg Score of 3/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are IMAC Holdings, Inc.'s main competitors?+
Named competitors include Tempus, Foundation Medicine, Guardant Health. The full competitive landscape is in the AskCyborg report.
How can I get the full IMAC Holdings, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the IMAC Holdings, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track IMAC Holdings, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual